Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The study assessed whether use of NCI's CIRB was associated with lower effort, time and cost in processing adult phase III oncology trials, which are the gold–standard of trials for validating whether a therapy becomes a new standard of care. Early phase trials and pediatric trials were not included in the analysis due to the lower patient enrollment populations required.

   

Today in Popular Press...keeping you current

Delivering medicine directly into a tumor
EurekAlert, 12/08/09

New understanding of how to prevent destruction of a tumor suppressor
EurekAlert, 12/08/09

Self-destructing bacteria improve renewable biofuel production
EurekAlert, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address